###BASE_URL###
2006-11-09 | permalink
Nov. 8 – The latest spat over genetic engineering centers on Oregon, where activists and regulators are battling over the safety of so-called "pharmacrops" – controversial plants genetically modified to produce medicine through "biopharming." In response to a bill proposed last year that would have put a moratorium on biopharming crops in Oregon, a state committee has recommended inviting biopharming in the state, with a few caveats. The committee wants the state to have a say in permit approval for the technology, as well as increased public access to the application process.
2006-11-09 | permalink
Nov. 8 – The latest spat over genetic engineering centers on Oregon, where activists and regulators are battling over the safety of so-called "pharmacrops" – controversial plants genetically modified to produce medicine through "biopharming." In response to a bill proposed last year that would have put a moratorium on biopharming crops in Oregon, a state committee has recommended inviting biopharming in the state, with a few caveats. The committee wants the state to have a say in permit approval for the technology, as well as increased public access to the application process.
GENET-news is providing a daily news service on a range of topics regarding genetic engineering. We are screening the worldwide English news, press releases and other publications to provide you with a strategic selection of information. GENET-news enables you to stay informed about all aspects of the global controversy around GE technologies and GE organisms. You can subscribe by email.
The GENET-forum list provides you with additional background information and more voluminous reports. It is only open for GENET members. Please contact the coordinator for membership and subscription.